Dr Marcel Doerflinger
Honorary (Fellow)
Department of Medical Biology (WEHI)
62 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Efferocytosis of apoptotic bodies drives SARS-CoV-2 infection and macrophage inflammation
DOI: 10.1038/s41467-026-74363-82026
Journal article
Immunophenotype and proviral landscape of HTLV-1c infection and pulmonary disease
DOI: 10.1016/j.ebiom.2026.1064032026
Journal article
Cas9-Expressing HC-04 Hepatocytes Facilitate CRISPR-Based Analysis of Plasmodium Falciparum Sporozoite-Host Interactions
DOI: 10.1371/journal.pgen.10121372026
Journal article
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4 T cells
DOI: 10.1038/s41467-026-74981-22026
Thesis / Dissertation
Defining and targeting host cell molecular pathways that contribute to systemic inflammatory response syndromes associated with Dengue infection
2025
Journal article
Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
DOI: 10.1038/s41467-025-65098-z2024
Research grants (ARC, NHMRC, MRFF)
Transforming Infection Management in the Era of Emerging Cancer Therapies
RECENT SCHOLARLY WORKS
2025
Journal article
Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses
DOI: 10.1038/s42003-025-08148-y2025
Journal article
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo
DOI: 10.1016/j.cell.2025.06.0232025
Journal article
Lipid nanoparticle-delivered intrabodies for inhibiting necroptosis and pyroptosis
DOI: 10.1042/bcj202531912025
Journal article
NLRP3 inflammasome–driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors
DOI: 10.1126/sciadv.adv00792025
Journal article
IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling
DOI: 10.1038/s41418-025-01459-x